DirkJan Hijnen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (14)

Claudia Lang

University Hospital of Zurich

SWITZERLAND

View details

Mübeccel Akdis

SWITZERLAND

View details

Joel Correa da Rosa

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Sander W. Tas

Professor of Rheumatology

Amsterdam UMC, University of Amsterdam

NETHERLANDS

View details

Willem A. Dik

NETHERLANDS

View details

Phyllis Spuls

prof. dr.

Academic Medical Center

NETHERLANDS

View details

Katja Baerenfaller

SWITZERLAND

View details

P. Hugo M. van der Kuy

Erasmus University Medical Center

NETHERLANDS

View details

Jill Olydam

Erasmus University Medical Center

NETHERLANDS

View details

Willem van de Veen

SWITZERLAND

View details

Jesper Elberling

Associate professor

University of Copenhagen

DENMARK

View details

Paul Lorenz Bigliardi

University of Minnesota

UNITED STATES

View details

Mirjam Schenk

institute of tissue medicine and pathology university of bern bern switzerland

SWITZERLAND

View details

Alan Irvine

Professor in Dermatology

Trinity College Dublin

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

DirkJan Hijnen

Research Interests

Explore related searches

Contact this professor

Articles (21)

Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforce

Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia

Long-term Outcomes of New Systemic Agents in Atopic Dermatitis: Drug Survival Analyses and Treatment Patterns in Daily Practice

The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema

Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration

T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination.

Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.

A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council

Higher prevalence of dupilumab-induced ocular adverse events in atopic dermatitis compared to asthma

Upadacitinib treatment in a real‐world difficult‐to‐treat atopic dermatitis patient cohort

Prediction of response to dupilumab treatment

Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry

Treat‐To‐Target in Dermatology: A Scoping Review and International Eczema Council Survey on the Approach in Atopic‐Dermatitis

Real‐world effectiveness of abrocitinib treatment in patients with difficult‐to‐treat atopic dermatitis

Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Adjusted dose regimens in dupilumab treatment for atopic dermatitis: Daily practice experiences

Baricitinib for atopic dermatitis patients who responded inadequately to dupilumab treatment: First daily practice results

Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study

Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient‐reported outcome measures

Collaborators (14)

Claudia Lang

Mübeccel Akdis

Joel Correa da Rosa

Sander W. Tas

Willem A. Dik

Phyllis Spuls

Katja Baerenfaller

P. Hugo M. van der Kuy

Jill Olydam

Willem van de Veen

Jesper Elberling

Paul Lorenz Bigliardi

Mirjam Schenk

Alan Irvine

Make your next move.